Iconic Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Iconic Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) (NCT03452527) | Iconic Therapeutics, Inc. | 2018-03-26 |
Track Iconic Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.